Urology · Austin, TX
NPI
1154394997
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
15534 Ranch Road 620 N Ste 100
Austin, TX, 78717
Phone (512) 231-1444
Groups this clinician bills Medicare through
Medicare paid, 2024
$379K
22,369 services
Medicare patients, 2024
1,055
Average age 76
Drug cost, 2024
$1.4M
6,379 prescriptions
Company payments, 2025
$6,642
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Melody A Denson was code J0585 (injection, onabotulinumtoxina, 1 unit), 12,500 times for 57 patients. In total Melody A Denson billed 22,369 services in 84 codes, and Medicare paid $379K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 12,500 | 57 | $4.98 | $62K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,100 | 21 | $0.10 | $218 |
| 81003 Clinical Chemistry | Office | 1,314 | 779 | $2.20 | $2,891 |
| 51798 Ultrasound - Nonspecific | Office | 1,282 | 791 | $8.43 | $11K |
| 99214 Office E&M - Established | Office | 1,107 | 698 | $87.90 | $97K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,062 | 202 | $47.24 | $50K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 786 | 572 | $11.84 | $9,304 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 577 | 173 | $36.80 | $21K |
| 99204 Office E&M - New | Office | 197 | 196 | $113.00 | $22K |
| 99459 Office/Outpatient Services | Office | 186 | 175 | $16.68 | $3,103 |
| 52287 Cystourethroscopy | Office | 88 | 57 | $288.38 | $25K |
| 36415 Venipuncture Blood Collection | Office | 74 | 72 | $8.65 | $640 |
| 99215 Office E&M - Established | Office | 43 | 42 | $131.51 | $5,655 |
| 52287 Cystourethroscopy | Facility | 31 | 21 | $105.38 | $3,267 |
| 52000 Cystourethroscopy | Office | 27 | 22 | $178.74 | $4,826 |
By year: 2022 $427K for 25,078 services; 2023 $407K for 21,271 services; 2024 $379K for 22,369 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,314 | 779 | $2.20 | $2,891 |
| 36415 Venipuncture Blood Collection | 74 | 72 | $8.65 | $640 |
| 82565 Clinical Chemistry | 19 | 19 | $5.02 | $95.38 |
Medicare prescription drug claims, 2024
In 2024, the drug Melody A Denson prescribed most often to Medicare patients was Gemtesa (Vibegron), with 765 prescriptions and refills. In total Melody A Denson wrote 6,379 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gemtesa Vibegron | 765 | 1,393 | 210 | $629K |
| Myrbetriq Mirabegron | 618 | 1,073 | 185 | $471K |
| Estradiol Generic | 494 | 1,647 | 255 | $24K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 407 | 437 | 314 | $5,475 |
| Cephalexin Generic | 397 | 771 | 174 | $7,140 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 386 | 836 | 121 | $7,901 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 354 | 760 | 133 | $14K |
| Tamsulosin Hcl Generic | 340 | 794 | 115 | $5,724 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 231 | 247 | 185 | $759 |
| Mirabegron Er Mirabegron | 195 | 384 | 78 | $105K |
| Progesterone Progesterone, Micronized | 179 | 367 | 45 | $8,148 |
| Trimethoprim Generic | 151 | 359 | 68 | $11K |
| Ciprofloxacin Hcl Generic | 123 | 123 | 102 | $587 |
| Solifenacin Succinate Generic | 120 | 305 | 41 | $4,415 |
| Methenamine Hippurate Generic | 119 | 192 | 41 | $8,107 |
Brand drugs: 1,746 claims; generic drugs: 4,615 claims; opioid claims: 130.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melody A Denson $6,642 ($6,642 in general payments such as food, travel and fees) from 18 companies. The largest payer was Medtronic, Inc. with $4,564.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 37 | $4,564 |
| Sumitomo Pharma America, Inc. 4506.T | 51 | $724 |
| Abbvie Inc. ABBV | 12 | $298 |
| Ferring Pharmaceuticals Inc. | 13 | $222 |
| Dendreon Pharmaceuticals LLC | 4 | $136 |
| Urogen Pharma, Inc. URGN | 6 | $115 |
| Pfizer Inc. PFE | 5 | $94.96 |
| Olympus America Inc. | 2 | $85.55 |
| Valencia Technologies Corporation | 3 | $72.04 |
| Janssen Biotech, Inc. JNJ | 4 | $69.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.